Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular diagnostics: hurdles for clinical implementation.

Paolo Fortina1, Saul Surrey, Larry J Kricka

  • 1Dept of Pediatrics, The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, 310-C Abramson Pediatric Research Center, 34th Street and Civic Center Boulevard, Philadelphia, PA 19104, USA. fortina@mail.med.upenn.edu

Trends in Molecular Medicine
|June 18, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: The Retinoblastoma Tumor Suppressor Modulates DNA Repair and Radioresponsiveness.

Clinical cancer research : an official journal of the American Association for Cancer Research·2024
Same author

Comparison of serum exosome miRNA from patients with Raynaud's phenomenon with positive and negative serum antinuclear antibodies.

Clinical and experimental rheumatology·2024
Same author

Skin in the game: a review of single-cell and spatial transcriptomics in dermatological research.

Clinical chemistry and laboratory medicine·2024
Same author

Toll-like receptor 4 signaling in osteoblasts is required for load-induced bone formation in mice.

iScience·2023
Same author

Transcription Factor RUNX3 Mediates Plasticity of ThGM Cells Toward Th1 Phenotype.

Frontiers in immunology·2022
Same author

Trends in dermatology eponyms.

JAAD international·2022
Same journal

Precision gene editing: From proof-of-concept to curative therapies.

Trends in molecular medicine·2026
Same journal

Targeting ferroptosis halts graft deterioration in transplantation.

Trends in molecular medicine·2026
Same journal

Amyotrophic lateral sclerosis: A rare but aggressive adult-onset disease.

Trends in molecular medicine·2026
Same journal

Urticaria: A debilitating disorder with emerging therapies.

Trends in molecular medicine·2026
Same journal

Gene therapy for aging and longevity.

Trends in molecular medicine·2026
Same journal

The emerging role of PPARs in primary biliary cholangitis.

Trends in molecular medicine·2026
See all related articles

Molecular diagnostics are vital for public health, aiding disease detection and drug response monitoring. Challenges remain in clinical implementation, but new technologies promise improved accuracy and accessibility.

Area of Science:

  • Molecular diagnostics
  • Genomics
  • Proteomics
  • Public Health

Background:

  • Molecular diagnostics are crucial for disease detection, characterization, drug response monitoring, and identifying genetic factors in susceptibility.
  • Current molecular tests assess DNA variation and gene expression, but face implementation hurdles in clinical settings.
  • Polymerase chain reaction (PCR)-based testing is predominant, but alternative technologies are emerging.

Purpose of the Study:

  • To highlight the growing importance of molecular diagnostics in public health.
  • To identify challenges in the clinical implementation of molecular diagnostic tests.
  • To discuss emerging technologies that will shape the future of molecular diagnostics.

Main Methods:

Related Experiment Videos

  • Review of current molecular diagnostic technologies and their applications.
  • Analysis of barriers to clinical laboratory implementation, including cost, accuracy, and training.
  • Exploration of emerging technologies like PCR-free methods and lab-on-a-chip devices.

    • Main Results:

    • Molecular diagnostics play a critical role in various aspects of healthcare and disease management.
    • Significant challenges exist in adopting molecular tests, including technological, economic, and regulatory factors.
    • Advancements in PCR-free technologies and integrated devices are expected to enhance molecular testing capabilities.

    Conclusions:

    • Molecular diagnostics are essential for future public health initiatives.
    • Overcoming implementation barriers is key to realizing the full potential of molecular diagnostics.
    • Emerging technologies, including lab-on-a-chip and proteomic-based tests, will revolutionize molecular diagnostics, presenting new opportunities and challenges.